'Clustering of exemptions' as a collective action threat to herd immunityMAY, Thomas; SILVERMAN, Ross D.Vaccine. 2003, Vol 21, Num 11-12, pp 1048-1051, issn 0264-410X, 4 p.Article

ZUR WIRKSAMKEIT VON PASTEURELLA MULTOCIDA - MUTANTEN DES SEROTYPES B = EFFICACITE DES MUTANTS DE PASTEURELLA MULTOCIDA SEROTYPE BPUTSCHE R.1981; ARCH. VET. (BUCUR.); ISSN 0003-9489; ROM; DA. 1981; VOL. 15; PP. 19-21; ABS. ENG/FRE/RUSArticle

Funding of drugs : do vaccines warrant a different approach? Authors' replyMITCHELL, Andrew S; ISAACS, David; BUTTERY, Jim et al.Lancet. Infectious diseases (print). 2009, Vol 9, Num 5, pp 269-271, issn 1473-3099, 3 p.Article

Public opponents of vaccination: a case studyLEASK, Julie; MCINTYRE, Peter.Vaccine. 2003, Vol 21, Num 32, pp 4700-4703, issn 0264-410X, 4 p.Article

Viral hepatitis: standardization in immunoprophylaxis of infections by hepatitis viruses. Proceedings of the second WHO/IABS symposium, held at the Caravel Hotel, Athens, Greece, November 15-18, 1982Developments in biological standardization. 1983, Vol 54, issn 0301-5149, XVIII-585 pConference Proceedings

Immunopropylactic approaches against chemical carcinogenesisDE BUCK, Stefan S; MULLER, Claude P.Vaccine. 2005, Vol 23, Num 17-18, pp 2403-2406, issn 0264-410X, 4 p.Conference Paper

Recherche des agglutinines irrégulières en milieu obstétrical en Tunisie: étude à propos de 5369 femmes = Irregular antibodies testing during pregnancy in Tunisia: Study about 5369 womenREKIK, T; AMOR, I. Ben; LOUATI, N et al.Transfusion clinique et biologique (Paris). 2012, Vol 19, Num 2, pp 64-73, issn 1246-7820, 10 p.Article

Communicating vaccine science to the publicLARRU, Beatriz; OFFIT, Paul.The Journal of infection. 2014, Vol 69, issn 0163-4453, S2-S4, SUP1Conference Paper

Characterizing Vaccine Responses Using Host Genomic and Transcriptomic AnalysisO'CONNOR, Daniel; POLLARD, Andrew J.Clinical infectious diseases. 2013, Vol 57, Num 6, pp 860-869, issn 1058-4838, 10 p.Article

Zoster Vaccine: Current Status and Future ProspectsOXMAN, Michael N.Clinical infectious diseases. 2010, Vol 51, Num 2, pp 197-213, issn 1058-4838, 17 p.Article

Vaccine components and constituents : respondinq to consumer concernsELDRED, Barbara E; DEAN, Angela J; MCGUIRE, Treasure M et al.Medical journal of Australia. 2006, Vol 184, Num 4, pp 170-175, issn 0025-729X, 6 p.Article

Can anti-idiotype vaccine help to circumvent parasite escape mechanisms?GRZYCH, J.-M; DEL GIUDICE, G; CAPRON, M et al.Monographs in allergy. 1987, Vol 22, pp 172-179, issn 0077-0760Conference Paper

EVALUATION OF THE PROPHYLACTIC EFFECT OF GAMMA GLOBULIN IN MENINGOCOCCAL INFECTIONPOKROVSKII VI; DEMINA AA; CEND N et al.1978; J. HYG. EPIDEMOL. MICROBIOL. IMMUNOL.; CSK; DA. 1978; VOL. 22; NO 2; PP. 230-236; ABS. FRE/GER/SPA; BIBL. 4 REF.Article

LA TACHYPHYLAXIEZEMSKOV MV; ZHURAVLEVA NV; ZEMSKOV AM et al.1977; USP. SOVREM. BIOL.; S.S.S.R.; DA. 1977; VOL. 83; NO 2; PP. 126-138; BIBL. 3 P.Article

Vaccination des sujets âgés de plus de 65 ans: un enjeu stratégique pour les années futures ! = The vaccination of older adults: A challenge for the future!BONNAL, Christine; DESAINT, Corinne; RAYNAUD-SIMON, Agathe et al.La Presse médicale (1983). 2013, Vol 42, Num 3, pp 318-326, issn 0755-4982, 9 p.Article

Why vaccine programmes can no longer ignore non-specific effectsAABY, Peter; WHITTLE, Hilton; STEBELL BENN, Christine et al.BMJ (Overseas and retired doctors ed.). 2012, Vol 345, Num 7864, pp 25-28, issn 1759-2151, 4 p.Article

Postpartum Rh ImmunoprophylaxisGERALD SANDLER, S; GOTTSCHALL, Jerome L.Obstetrics and gynecology (New York. 1953). 2012, Vol 120, Num 6, pp 1428-1438, issn 0029-7844, 11 p.Article

The next decade of vaccines: societal and scientific challengesMOXON, E. Richard; SIEGRIST, Claire-Anne.Lancet (British edition). 2011, Vol 378, Num 9788, pp 348-359, issn 0140-6736, 12 p.Article

Rethinking global access to vaccinesCHOKSHI, Dave A; KESSELHEIN, Aaron S.BMJ. British medical journal (International ed.). 2008, Vol 336, Num 7647, pp 750-753, issn 0959-8146, 4 p.Article

Quelle place pour le BCG en France ? = What place for BCG vaccination in France?LEVY-BRUHL, D.Archives de pédiatrie (Paris). 2002, Vol 9, Num 1, pp 1-3, issn 0929-693XArticle

FAUT-IL VACCINER LES CANCEREUX.LACUT JY.1980; CONCOURS MED.; FRA; DA. 1980; VOL. 102; NO 21; PP. 3225-3231; (5 P.); BIBL. 7 REF.Article

DIE HEUTIGE IMMUNOPROPHYLAXE DER TOLLWUT = IMMUNOPROPHYLAXIE ACTUELLE CONTRE LA RAGEMAJER M.1979; MED. KLIN.; DEU; DA. 1979; VOL. 74; NO 45; PP. 1658-1663; BIBL. 30 REF.Article

PROBLEME DE L'IMMUNOPROPHYLAXIE DES MENINGOCOCCIESEFIMOV DD; BELOVA TN.1979; ZH. MIKROBIOL. EPIDEMIOL. IMMUNOBIOL.; SUN; DA. 1979; NO 7; PP. 23-29; BIBL. 41 REF.Article

SOME PROBLEMS OF MODERN INFLUENZA PROPHYLAXIS WITH LIVE VACCINE.ZHILOVA GP; ALEXANDROVA GI; ZYKOV MP et al.1977; J. INFECT. DIS.; U.S.A.; DA. 1977; VOL. 135; NO 4; PP. 681-686; BIBL. 13 REF.Article

Vaccine AdjuvantsREED, Steven G.Expert review of vaccines. 2013, Vol 12, Num 7, issn 1476-0584, [112 p.]Serial Issue